PD-L1 expression and survival in patients with locally advanced cervical cancer treated with chemoradiotherapy

被引：0
|
作者：
Enwere, E. [1 ]
Kornaga, E. [2 ]
Koulis, T. [3 ]
Dean, M. [2 ]
Phan, T. [3 ]
Ghatage, P. [4 ]
Magliocco, A. [5 ]
Lees-Miller, S. [6 ]
Doll, C. [3 ]
机构：
[1] Tom Baker Canc Clin, Pathol & Lab Med, Translat Lab, Funct Tissue Imaging Unit, Calgary, AB, Canada
[2] Tom Baker Canc Clin, Pathol & Lab Med, Translat Lab, Calgary, AB, Canada
[3] Univ Calgary, Oncol, Calgary, AB, Canada
[4] Univ Calgary, Gynecol Oncol, Calgary, AB, Canada
[5] Univ S Florida, H Lee Moffitt Canc Ctr, Anat Pathol, Tampa, FL 33682 USA
[6] Univ Calgary, Oncol Biochem & Mol Biol, Calgary, AB, Canada
来源：
EUROPEAN JOURNAL OF CANCER | 2015年 / 51卷
关键词：
D O I：
10.1016/S0959-8049(16)30198-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
334
引用
收藏
页码：S65 / S65
页数：1
相关论文
共 50 条
  • [41] PD-L1 expression and overall survival in Asian and western patients with gastric cancer
    Rha, Sun Young
    Ku, Geoffrey Y.
    Kim, Hyo Song
    Chung, Hyun Cheol
    Amlashi, Fatemeh Ghazanfari
    Maru, Dipen Maheshbhai
    Fein, Carly A.
    Tang, Laura H.
    Zhou, Wei
    Wu, Ting
    Peter, Senaka A.
    Kelsen, David P.
    Ajani, Jaffer A.
    FUTURE ONCOLOGY, 2022, 18 (21) : 2623 - 2634
  • [42] PD-L1 expression as a prognostic marker in patients with advanced biliary tract cancer
    Kim, H.
    Kim, J.
    Byeon, S.
    Hong, J. Y.
    Lee, J.
    Park, S. H.
    Park, J. O.
    Park, Y. S.
    Lim, H. Y.
    Kang, W. K.
    Kim, S. T.
    ANNALS OF ONCOLOGY, 2020, 31 : S267 - S267
  • [43] Circulating miRNAs and PD-L1 Tumor Expression Are Associated with Survival in Advanced NSCLC Patients Treated with Immunotherapy: a Prospective Study
    Boeri, Mattia
    Milione, Massimo
    Proto, Claudia
    Signorelli, Diego
    Lo Russo, Giuseppe
    Galeone, Carlotta
    Verri, Carla
    Mensah, Mavis
    Centonze, Giovanni
    Martinetti, Antonia
    Sottotetti, Elisa
    Pastorino, Ugo
    Garassino, Marina Chiara
    Sozzi, Gabriella
    CLINICAL CANCER RESEARCH, 2019, 25 (07) : 2166 - 2173
  • [44] Prognostic Value of Hematological Parameters in Locally Advanced Cervical Cancer Patients Treated With Concurrent Chemoradiotherapy
    Lee, Hyun Jung
    Kim, Jong Mi
    Chin, Yoo Jeong
    Chong, Gun Oh
    Park, Shin-Hyung
    Lee, Yoon Hee
    Hong, Dae Gy
    Lee, Yoon Soon
    ANTICANCER RESEARCH, 2020, 40 (01) : 451 - 458
  • [45] Pelvic node control in patients with locally advanced uterine cervical cancer treated with concurrent chemoradiotherapy
    Toita, T.
    Nagai, Y.
    Tamaki, W.
    Ogawa, K.
    Gibo, S.
    Kakinohana, Y.
    Kamiyama, K.
    Inamine, M.
    Aoki, Y.
    Murayama, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [46] PD-L1 expression associates with favorable survival of patients with cancer of unknown primary (CUP) not treated with checkpoint inhibitors
    Abu Sabbah, Tanja
    Theurer, Sarah
    Baba, Hideo Andreas
    Lueong, Smiths
    Rashidi-Alavijeh, Jassin
    Hilser, Thomas
    Zaun, Yasmin
    Metzenmacher, Martin
    Pogorzelski, Michael
    Virchow, Isabel
    Pretzell, Ina
    Kostbade, Karina
    Treckmann, Jurgen
    Wiesweg, Marcel
    Schuler, Martin
    Kasper, Stefan
    Zaun, Gregor
    EUROPEAN JOURNAL OF CANCER, 2024, 210
  • [47] Programmed Death Ligand 1 (PD-L1) Expression in Cervical Cancer
    Lathika, Aryakrishna S.
    Lakshmi, S.
    Ramdas, Preethi T.
    Kumar, Aswin
    Mathews, Susan
    Joseph, John
    Mathew, Aleyamma
    James, Francis V.
    INDIAN JOURNAL OF GYNECOLOGIC ONCOLOGY, 2021, 19 (04)
  • [48] Programmed Death Ligand 1 (PD-L1) Expression in Cervical Cancer
    Aryakrishna S. Lathika
    S. Lakshmi
    Preethi T. Ramdas
    Aswin Kumar
    Susan Mathews
    John Joseph
    Aleyamma Mathew
    Francis V. James
    Indian Journal of Gynecologic Oncology, 2021, 19
  • [49] Role of IDO expression in patients with locally advanced rectal cancer treated with preoperative chemoradiotherapy
    Takasu, Chie
    Nishi, Masaaki
    Yoshikawa, Kozo
    Tokunaga, Takuya
    Nakao, Toshihiro
    Kashihara, Hideya
    Wada, Yuma
    Yoshimoto, Toshiaki
    Okikawa, Shohei
    Yamashita, Shoko
    Shimada, Mitsuo
    BMC CANCER, 2022, 22 (01)
  • [50] Role of IDO expression in patients with locally advanced rectal cancer treated with preoperative chemoradiotherapy
    Chie Takasu
    Masaaki Nishi
    Kozo Yoshikawa
    Takuya Tokunaga
    Toshihiro Nakao
    Hideya Kashihara
    Yuma Wada
    Toshiaki Yoshimoto
    Shohei Okikawa
    Shoko Yamashita
    Mitsuo Shimada
    BMC Cancer, 22
12345